脑黏液瘤性动脉瘤:病例系列及具备充分随访期与动脉瘤壁活检结果的文献系统综述
本研究报道本院治疗的4例脑黏液瘤性动脉瘤(CMA)患者,并通过PubMed和Embase系统检索纳入具备充分随访期和动脉瘤壁活检结果的英文文献。共分析149例保守治疗的CMA,其中9例增大、6例缩小、134例稳定,总动脉瘤年数为453.33;因CMA破裂导致出血的15例中7例(46.67%)预后不良。13例有动脉瘤活检结果,其中11例显示动脉瘤壁肿瘤侵犯。
要点
- 保守治疗的CMA中9例增大、6例缩小、134例稳定,总随访453.33动脉瘤年。
- CMA破裂出血(脑实质或蛛网膜下腔出血)的15例中7例(46.67%)预后不良。
- 13例动脉瘤活检中11例显示动脉瘤壁肿瘤侵犯,肿瘤细胞存在可能促进不良病程。
核心结论
- 未破裂、外观良性的CMA自然病程似乎较好,但动脉瘤内有无存活肿瘤细胞可能促进不良病程。
- 对于大型、有症状且增大的CMA,因破裂所致死亡率和致残率可能较高,应考虑手术、血管内或联合治疗。
研究设计与样本
- 本研究描述本院治疗的4例CMA患者,并通过PubMed和Embase数据库进行文献检索。
- 检索关键词为「cerebral myxomatous aneurysm」「myxomatous aneurysm」「cardiac myxoma」和「intracranial aneurysm」。
- 仅纳入英文发表、与本疾病相关、具备充分随访期和动脉瘤壁活检结果的文献,分析临床、影像、病理和治疗特征。
主要发现
- 共149例CMA接受保守治疗,包括9例增大、6例缩小和134例稳定,总动脉瘤年数为453.33(分别对应每动脉瘤年1.91%、1.27%和28.76%)。
- 因CMA破裂导致出血(脑实质或蛛网膜下腔出血)的15例中7例(46.67%)预后不良。
- 13例有动脉瘤活检结果,其中11例显示动脉瘤壁肿瘤侵犯。
临床怎么用
- 对于大型、有症状且增大的CMA,作者认为应考虑手术、血管内或联合治疗,因破裂所致死亡率和致残率可能较高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral myxomatous aneurysms (CMA) are intracranial aneurysms caused by cardiac myxoma. The exact mechanism underlying their development has not yet been elucidated. And an optimal treatment method has not yet been established because of rarity of the disease. In addition, most existing reports have had a short follow-up period or lack of follow-up imaging test results. The aim of this study was to provide better insights into the course and treatment options of CMAs. METHODS: We describe 4 CMA patients treated in our hospital and literature search was performed using PubMed and Embase databases. Keywords used were as follows: "cerebral myxomatous aneurysm", "myxomatous aneurysm", "cardiac myxoma", and "intracranial aneurysm". Only publications in English and related to this disorder with adequate follow-up periods and aneurysmal wall biopsy results were included. Clinical, radiological, pathological, and treatment characteristics were analyzed. RESULTS: A total of 149 CMA cases were managed conservatively that included 9 enlargements, 6 regressions, and 134 stable aneurysms, which were identified for a total of 453.33 aneurysm years (1.91% per aneurysm year, 1.27% per aneurysm year, and 28.76% per aneurysm year, respectively). Poor outcome rate was high in cases with hemorrhage (either parenchymal or subarachnoidal hemorrhage) due to rupture of the CMA (46.67%, 7 out of 15). Thirteen cases had aneurysm biopsy results of which 11 showed tumor invasion on the aneurysm wall. CONCLUSIONS: Even though the natural course of unruptured, benign-looking CMAs appears to be favorable, the presence or absence of viable tumor cells in the aneurysm may promote an unfavorable disease course. In the case of large, symptomatic, and enlarging CMAs, surgical, endovascular, or combined treatment should be considered as the mortality and morbidity due to rupture might be high.
引用
- Choi JH, Park W, Park JC, et al. Cerebral Myxomatous Aneurysms: Case Series and Systematic Review of Literature with Adequate Follow-Up Periods and Aneurysmal Wall Biopsy Results. World Neurosurg. 2022. PMID: 36566979. doi:10.1016/j.wneu.2022.12.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。